Abstract
Collagen-induced arthritis (CIA) is a chronic inflammatory disease bearing all the hallmarks of rheumatoid arthritis, e.g. polyarthritis, synovitis, and subsequent cartilage/bone erosions. One feature of the disease contributing to joint damage is synovial hyperplasia. The factors responsible for the hyperplasia are unknown; however, an imbalance between rates of cell proliferation and cell death (apoptosis) has been suggested. To evaluate the role of a major pathway of cell death – Fas (CD95)/FasL – in the pathogenesis of CIA, DBA/1J mice with a mutation of the Fas gene (lpr) were generated. The susceptibility of the mutant DBA-lpr/lpr mice to arthritis induced by collagen type II was evaluated. Contrary to expectations, the DBA-lpr/lpr mice developed significantly milder disease than the control littermates. The incidence of disease was also significantly lower in the lpr/lpr mice than in the controls (40% versus 81%; P < 0.05). However DBA-lpr/lpr mice mounted a robust immune response to collagen, and the expression of local proinflammatory cytokines such as, e.g., tumor necrosis factor α (TNF-α) and IL-6 were increased at the onset of disease. Since the contribution of synovial fibroblasts to inflammation and joint destruction is crucial, the potential activating effect of Fas on mouse fibroblast cell line NIH3T3 was investigated. On treatment with anti-Fas in vitro, the cell death of NIH3T3 fibroblasts was reduced and the expression of proinflammatory cytokines TNF-α and IL-6 was increased. These findings suggest that impairment of immune tolerance by increased T-cell reactivity does not lead to enhanced susceptibility to CIA and point to a role of Fas in joint destruction.
Similar content being viewed by others
Abbreviations
- AICD:
-
activation-induced cell death
- CFA:
-
complete Freund's adjuvant
- CIA:
-
collagen-induced arthritis
- ConA:
-
concanavalin A
- ELISA:
-
enzyme-linked immunosorbent assay
- Fab:
-
antigen-binding fragment
- FACS:
-
fluorescence-activated cell sorter
- FasL:
-
Fas ligand
- FITC:
-
fluorescein isothiocyanate
- IFN:
-
interferon
- IL:
-
interleukin
- mAb:
-
monoclonal antibody
- PBS:
-
phosphate-buffered saline
- PCR:
-
polymerase chain reaction
- PE:
-
phycoerythrin
- RA:
-
rheumatoid arthritis
- RPMI:
-
Roswell Park Memorial Institute [medium]
- TNF:
-
tumor necrosis factor.
References
Trentham DE, Townes AS, Kang AH: Autoimmunity to type II collagen: an experimental model of arthritis. J Exp Med. 1977, 146: 857-868. 10.1084/jem.146.3.857.
Staines NA, Wooley PH: Collagen arthritis-what can it teach us?. Br J Rheumatol. 1994, 33: 798-807.
Wooley PH, Luthra HS, Stuart JM, David CS: Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med. 1981, 154: 688-700. 10.1084/jem.154.3.688.
Stuart JM, Watson WC, Kang AH: Collagen autoimmunity and arthritis. FASEB J. 1988, 2: 2950-2956.
Kinne RW, Palombo-Kinne E, Emmrich F: T-cells in the pathogenesis of rheumatoid arthritis, villains or accomplices?. Biochim Biophys Acta. 1997, 1360: 109-141. 10.1016/S0925-4439(96)00079-8.
Berek C, Kim HJ: B-cell activation and development within chronically inflamed synovium in rheumatoid and reactive arthritis. Semin Immunol. 1997, 9: 261-268. 10.1006/smim.1997.0076.
Firesstein GS, Yeo M, Zvaifler NJ: Apoptosis in rheumatoid arthritis synovium. J Clin Invest. 1995, 96: 1631-1638.
Osborne BA: Apoptosis and the maintenance of homeostasis in the immune system. Curr Opin Immunol. 1996, 8: 245-254. 10.1016/S0952-7915(96)80063-X.
Nagata S, Golstein P: The Fas death factor. Science. 1995, 267: 1449-1456.
Singer GG, Abbas AK: The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity. 1994, 1: 365-371. 10.1016/1074-7613(94)90067-1.
Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ: Induction of apoptosis in mature T cells by tumor necrosis factor. Nature. 1995, 377: 348-351. 10.1038/377348a0.
Griffiths GM: The cell biology of CTL killing. Curr Opin Immunol. 1995, 7: 343-348. 10.1016/0952-7915(95)80108-1.
Lee RK, Spielman J, Zhao DY, Olsen KJ, Podack ER: Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells. J Immunol. 1996, 157: 1919-1925.
Douni E, Akassoglou K, Alexopoulou L, Georgopoulos S, Haralambous S, Hill S, Kassiotis G, Kontoyiannis D, Pasparakis M, Plows D, Probert L, Kollias G: Transgenic and knockout analysis of the role of TNF in immune regulation and disease pathogenesis. J Inflamm. 1996, 47: 27-38.
Mori L, Iselin S, De Libero G, Lesslauer W: Attenuation of collagen-induced arthritis in 55 kDa TNF receptor type I (TNFR1)-IgG1-treated and TNFR1-deficient mice. J Immunol. 1996, 157: 3178-3182.
Salmon M, Scheel-Toellner D, Huissoon AP, Pilling D, Shamasadeen N, Hyde H, D'Andeac AD, Bacon PA, Emery P, Akbar AN: Inhibition of T cell apoptosis in the rheumatoid synovium. J Clin Invest. 1997, 99: 439-446.
Schirmer M, Vallejo AN, Weyand CM, Goronzy JJ: Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4+CD28- T cells from rheumatoid arthritis patients. J Immunol. 1998, 161: 1018-1025.
Mysler E, Bini P, Drappa J, Ramos P, Friedman SM, Krammer PH, Elkon KB: The apoptosis-1/Fas protein in human systemic lupus erythematosus. J Clin Invest. 1994, 93: 1029-1034.
Amasaki Y, Kobayashi S, Takeda T, Ogura N, Jodo S, Nakabayashi T, Tsutsumi A, Fujisaku A, Koike T: Up-regulated expression of Fas antigen (CD95) by peripheral naive and memory T cell subsets in patients with systemic lupus erythematosus (SLE): a possible mechanism for lymphopenia. Clin Exp Immunol. 1995, 99: 245-250.
Sakata K, Sakata A, Vela-Roch N, Espinosa R, Escalante A, Kong L, Nakabayashi T, Cheng J, Talal N, Dang H: Fas (CD95)-transduced signal preferentially stimulates lupus peripheral T lymphocytes. Eur J Immunol. 1998, 28: 2648-2660. 10.1002/(SICI)1521-4141(199809)28:09<2648::AID-IMMU2648>3.0.CO;2-M.
Kamogawa J, Terada M, Mizuki S, Nishihara M, Yamamoto H, Mori S, Abe Y, Morimoto K, Nakatsuru S, Nakamura Y, Nose M: Arthritis in MRL/lpr mice is under the control of multiple gene loci with an allelic combination derived from the original inbred strains. Arthritis Rheum. 2002, 46: 1067-1074. 10.1002/art.10193.
Sugiyama M, Tsukazaki T, Yonekura A, Matsuzaki S, Yamashita S, Iwasaki K: Localization of apoptosis and expression of apoptosis related proteins in the synovium of patients with rheumatoid arthritis. Ann Rheum Dis. 1996, 55: 442-449.
Cantwell MJ, Hua T, Zvaifler NJ, Kipps TJ: Deficient Fas ligand expression by synovial lymphocytes from patients with rheumatoid arthritis. Arthritis Rheum. 1997, 40: 1644-1652.
Hasunuma T, Hoa TTM, Aono H, Asahara H, Yonehara S, Yamamoto K, Sumida T, Gay S, Nishioka K: Induction of Fas-dependent apoptosis in synovial infilterating cells in rheumatoid arthritis. Int Immunol. 1996, 8: 1595-1602.
Holmdahl R, Jonsson R, Larsson P, Klareskog L: Early appearance of activated CD4+ T lymphocytes and class II antigen-expressing cells in joints of DBA/1 mice immunized with type II collagen. Lab Invest. 1988, 58: 53-60.
Giordano C, Stassi G, De Maria R, Todaro M, Richiusa P, Papoff G, Ruberti G, Bagnasco M, Testi R, Galluzzo A: Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science. 1997, 275: 960-963.
D'Souza SD, Bonetti B, Balasingam V, Cashman NR, Barker PA, Troutt AB, Raine CS, Antel JP: Multiple clerosis: Fas signaling in oligodendrocyte cell death. J Exp Med. 1996, 184: 2361-2370. 10.1084/jem.184.6.2361.
Dowling P, Shang G, Raval S, Menonna J, Cook S, Husar W: Involvement of the CD95 (APO-1/Fas) receptor/ligand in multiple sclerosis brain. J Exp Med. 1996, 184: 1513-1518. 10.1084/jem.184.4.1513.
Chervonsky AV, Wang Y, Wong FS, Visintin I, Flavell RA, Janeway CA, Matis LA: The role of Fas in autoimmune diabetes. Cell. 1997, 89: 17-24. 10.1016/S0092-8674(00)80178-6.
Feldmann M: Development of anti-TNF therapy for rheumatoid arthritis. Nat Rev Immunol. 2002, 2: 364-371. 10.1038/nri802.
Sabelko KA, Kelly KA, Nahm MH, Cross AH, Russell JH: Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system. J Immunol. 1997, 159: 3096-3099.
Dittel BN, Merchant RM, Janeway CA: Evidence for Fas-dependent and Fas-independent mechanisms in the pathogenesis of experimental autoimmune encephalomyelitis. J Immunol. 1999, 162: 6392-6400.
Kuhn K, Lotz M: Regulation of CD95 (Fas/APO-1)-induced apoptosis in human chondrocytes. Arthritis Rheum. 2001, 44: 1644-1653. 10.1002/1529-0131(200107)44:7<1644::AID-ART287>3.0.CO;2-S.
Aggrawal BB, Singh S, LaPushin R, Totpal K: Fas antigen signals proliferation of normal human diploid fibroblast and mechanism its different from tumor necrosis factor. FEBS Lett. 1995, 364: 5-8. 10.1016/0014-5793(95)00339-B.
Chou CT, Yang JS, Lee MR: Apoptosis in rheumatoid arthritis – expression of Fas, Fas-L, p53, and Bcl-2 in rheumatoid synovial tissues. J Pathol. 2001, 193: 110-116. 10.1002/1096-9896(2000)9999:9999<::AID-PATH746>3.0.CO;2-K.
Ford MS, Young KJ, Zhang Z, Ohashi PS, Zhang L: The immune regulatory function of lymphoproliferative double negative T cells in vitro and in vivo. J Exp Med. 2002, 196: 261-267. 10.1084/jem.20020029.
Alonzi T, Fattori E, Lazzaro D, Costa P, Probert L, Kollias G, De Benedetti F, Poli V, Ciliberto G: Interleukin 6 is required for the development of collagen-induced arthritis. J Exp Med. 1998, 187: 461-468. 10.1084/jem.187.4.461.
Joosten LA, Helsen MM, van de Loo FA, van den Berg WB: Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF. Arthritis Rheum. 1996, 39: 797-809.
Williams RO, Feldmann M, Maini RN: Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci USA. 1992, 89: 9784-9788.
Doncarli A, Stasiuk LM, Fournier C, Abehsira-Amar O: Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis. Eur J Immunol. 1997, 27: 1451-1458.
Mauri C, Williams RO, Walmsley M, Feldmann M: Relationship between Th1/Th2 cytokine pattern and the arthritogenic response in collagen-induced arthritis. Eur J Immunol. 1996, 26: 1511-1518.
Brennan FM, Field M, Chu CQ, Feldmann M, Maini RN: Cytokine expression in rheumatoid arthritis. Br J Rheumatol. 1991, 1: 76-80.
Klareskog L, McDevitt HO: Rheumatoid arthritis and its animal models: the role of TNF-alpha and the possible absence of specific immune responses. Curr Opin Immunol. 1999, 11: 657-662. 10.1016/S0952-7915(99)00033-3.
Mihara M, Moriya Y, Kishimoto T, Ohsugi Y: Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor. Br J Rheumatol. 1995, 34: 321-325.
Ma Y, Liu H, Tu-Rapp H, Thiesen HJ, Ibrahim SM, Cole SM, Pope RM: Fas ligation on macrophages enhances IL-1R1/Toll-like receptor 4 signaling and promotes chronic inflammation. Nat Immunol. 2004, 5: 380-387. 10.1038/ni1054.
Asahara H, Hasunuma T, Kobata T, Inoue H, Muller-Lander U, Gay S, Sumida T, Nishioka K: In situ expression of protooncogenes and Fas/Fas ligand in rheumatoid arthritis synovium. J Rheumatol. 1997, 24: 430-435.
Acknowledgements
The authors would like to thank Ms Ilona Klamfuss and Ms Eva Lorbeer for excellent technical assistance. This work is supported by grant IB24/3-2 from the DFG (German Research Foundation) and FKZ 01ZZ0108 from the BMBF (Federal Ministry for Research) to SMI.
Author information
Authors and Affiliations
Corresponding author
Additional information
Competing interests
None declared.
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
Rights and permissions
About this article
Cite this article
Tu-Rapp, H., Hammermüller, A., Mix, E. et al. A proinflammatory role for Fas in joints of mice with collagen-induced arthritis. Arthritis Res Ther 6, R404 (2004). https://doi.org/10.1186/ar1205
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1186/ar1205